Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MW-032 by Mabwell Shanghai Bioscience for Bone Metastasis: Likelihood of Approval
MW-032 is under clinical development by Mabwell Shanghai Bioscience and currently in Phase III for Bone Metastasis. According to GlobalData,...